NFA
PGNX

Nationwide Fund Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Nationwide Fund Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-38,428
Closed -$283K – 2679
2017
Q3 		$283K Sell
38,428
-1,807
-4% -$11.5K ﹤0.01% 2467
2017
Q2 		$273K Sell
40,235
-1,578
-4% -$11.6K ﹤0.01% 2492
2017
Q1 		$395K Sell
41,813
-692
-2% -$6.91K ﹤0.01% 2273
2016
Q4 		$367K Sell
42,505
-1,699
-4% -$12.6K ﹤0.01% 2339
2016
Q3 		$280K Hold
44,204
– – ﹤0.01% 2461
2016
Q2 		$187K Hold
44,204
– – ﹤0.01% 2649
2016
Q1 		$193K Sell
44,204
-2,179
-5% -$9.7K ﹤0.01% 2550
2015
Q4 		$284K Buy
46,383
+1,063
+2% +$6.97K ﹤0.01% 2380
2015
Q3 		$259K Hold
45,320
– – ﹤0.01% 2439
2015
Q2 		$338K Sell
45,320
-5,569
-11% -$33.7K ﹤0.01% 2455
2015
Q1 		$304K Sell
50,889
-2,650
-5% -$16.7K ﹤0.01% 2488
2014
Q4 		$405K Sell
53,539
-775
-1% -$4.64K ﹤0.01% 2304
2014
Q3 		$282K Buy
54,314
+130
+0.2% +$648 ﹤0.01% 2532
2014
Q2 		$234K Buy
54,184
+1,722
+3% +$6.58K ﹤0.01% 2673
2014
Q1 		$215K Buy
52,462
+6,201
+13% +$31.7K ﹤0.01% 2460
2013
Q4 		$247K Sell
46,261
-26,033
-36% -$115K ﹤0.01% 2590
2013
Q3 		$364K Buy
72,294
+11,076
+18% +$60.1K ﹤0.01% 2378
2013
Q2 		$273K Buy
+61,218
New +$275K ﹤0.01% 2344

Other funds holding PGNX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $637M AUM 39.08% 1-Year Est. Return

Nationwide Fund Advisors's PGNX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Progenics Pharmaceuticals Inc (PGNX) in Q4 2017, closing a stake of 38,428 shares — an estimated $283K sold.

Nationwide Fund Advisors first reported a position in PGNX in Q2 2013 and held it in 18 quarters. The position peaked at $405K in Q4 2014. 153 funds tracked by Wall St. Rank hold PGNX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Progenics Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 38,428 Progenics Pharmaceuticals Inc shares in Q4 2017, an estimated $283K.
  • Nationwide Fund Advisors first reported a position in Progenics Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Progenics Pharmaceuticals Inc position peaked at $405K in Q4 2014.
  • 153 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.